Dublin, Dec. 14, 2020 (GLOBE NEWSWIRE) -- The "Drug Screening Market by Product (Consumables, Urine testing devices, Analytical, Breathalyzer, Chromatography) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3% during the forecast period.
Market growth can be largely attributed to factors such as the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches. The emerging countries are also expected to offer strong growth opportunities for players in the market. On the other hand, bans on alcohol consumption in Islamic countries and the prohibition of drug testing at workplaces in certain regions are some major factors that may hinder the market growth.
Drug screening services are expected to grow at the highest CAGR during the forecast period
Drug screening market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period, growth in this segment is attributed to factors such as the growing drug and alcohol consumption worldwide, funding initiatives for drug testing laboratories, new and regular service launches and regulatory approvals, and the geographic expansion of drug and alcohol testing laboratories.
By sample type, urine samples are expected to dominate the market during the forecast period
The drug screening market is segmented into urine, breath, hair, oral, and other samples on the basis of sample type. The urine sample segment is expected to dominate the market during the forecast period due to the benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.
North America will dominate the market during the forecast period
Geographically, the drug screening market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the drug screening market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the growing consumption of illicit drugs, rising number of drunk-driving cases, growing awareness regarding drug screening tests and the strategic expansion of the market players in the region.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Attractive Opportunities in the Drug Screening Market
4.2 Drug Screening Market, by Product & Service
4.3 Drug Screening Market, by Sample Type
4.4 Drug Screening Market: Geographic Snapshot
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Growing Drug and Alcohol Consumption
5.3.1.2 Enforcement of Stringent Laws Mandating Drug and Alcohol Testing
5.3.1.3 Regulatory Approvals and Product & Service Launches
5.3.2 Restraints
5.3.2.1 Ban on Alcohol Consumption in Several Islamic Countries
5.3.2.2 Prohibition on Workplace Drug Testing in Some Countries
5.3.3 Opportunities
5.3.3.1 Oral Fluid Testing
5.3.3.2 Fingerprint-Based Drug Screening
5.3.3.3 Emerging Economies
5.3.4 Challenges
5.3.4.1 Accuracy and Specificity Concerns Related to Breathalyzers
5.4 Value Chain Analysis
5.5 Ecosystem Analysis of the Drug Screening Products Market
5.6 COVID-19 Impact on the Drug Screening Market
6 Drug Screening Market, by Product & Service
6.1 Introduction
6.2 Drug Screening Services
6.2.1 Growing Drug Consumption and Stringent Laws Have Ensured Demand Spike for Services
6.3 Drug Screening Products
6.3.1 Analytical Instruments
6.3.1.1 Breathalyzers
6.3.1.1.1 Law Enforcement Agencies Widely Use Breathalyzers
6.3.1.1.2 Fuel-Cell Breathalyzers
6.3.1.1.3 Semiconductor Breathalyzers
6.3.1.1.4 Other Breathalyzers
6.3.1.2 Immunoassay Analyzers
6.3.1.2.1 North America is the Largest Market for Immunoassay Analyzers
6.3.1.3 Chromatography Instruments
6.3.1.3.1 Chromatography Shows Higher Accuracy Than Immunoassays
6.3.2 Rapid Testing Devices
6.3.2.1 Urine Testing Devices
6.3.2.1.1 Urine Testing Provides Results Within Minutes and is Used in a Wide Range of Applications
6.3.2.1.2 Drug Testing Cups
6.3.2.1.3 Dip Cards
6.3.2.1.4 Drug Testing Cassettes
6.3.2.2 Oral Fluid Testing Devices
6.3.2.2.1 Short Detection Windows, Noninvasive Nature, and Low Chance of Sample Tampering Have Ensured Interest in Oral Fluid Testing
6.3.3 Consumables
6.3.3.1 Assay Kits
6.3.3.1.1 Immunoassay Kits Provide a Rapid, Inexpensive Method to Screen Samples
6.3.3.2 Sample Collection Devices
6.3.3.2.1 APAC Market for Sample Collection Devices to See High Growth
6.3.3.3 Calibrators & Controls
6.3.3.3.1 Thermo Fisher Scientific is a Prominent Manufacturer of Calibrators & Controls
6.3.3.4 Other Consumables
7 Drug Screening Market, by Sample Type
7.1 Introduction
7.2 Urine Samples
7.2.1 Ease of Collection and Well-Developed Technology Have Supported the Use of Urine Samples
7.3 Breath Samples
7.3.1 Breath Alcohol Tests See Wide Usage in Workplace Testing and Law Enforcement Applications
7.4 Oral Fluid Samples
7.4.1 Noninvasive Sample Collection and Low Chance of Adulteration Have Supported Reliance on Oral Samples
7.5 Hair Samples
7.5.1 Hair Samples Can Provide Insights into Long-Term Drug Use
7.6 Other Samples
8 Drug Screening Market, by End-user
8.1 Introduction
8.2 Workplaces
8.2.1 Workplaces to Show the Highest Growth of All End-User Segments
8.3 Drug Testing Laboratories
8.3.1 Rising Number of Drug Abuse Cases and Development of Specialized Assays and Tests Support Market Growth
8.4 Criminal Justice Systems & Law Enforcement Agencies
8.4.1 Urine is the Most Commonly Used Sample in Criminal Justice Systems
8.5 Hospitals
8.5.1 Rising Drug Abuse Incidence Has Resulted in An Increase in Emergency Department Visits
8.6 Drug Treatment Centers
8.6.1 Availability of Government Support is a Key Growth Driver
8.7 Individual Users
8.7.1 Personal Breathalyzers Have Seen Growing Adoption
8.8 Pain Management Centers
8.8.1 Rising Substance Abuse Has Supported Drug Testing Activity in Pain Management Applications
8.9 Schools & Colleges
8.9.1 while Some Countries Support Drug Tests in Schools & Colleges, Others Are Opposed or Have Banned Testing
9 Drug Screening Market, by Region
9.1 Introduction
9.2 North America
9.3 Europe
9.4 APAC
9.5 RoW
10 Competitive Landscape
10.1 Overview
10.2 Competitive Situations and Trends
10.2.1 Partnerships, Agreements, and Collaborations (2017-2020)
10.2.2 Product Launches (2017-2020)
10.2.3 Approvals (2017-2020)
10.2.4 Expansions (2017-2020)
10.2.5 Acquisitions (2017-2020)
11 Company Evaluation Matrix and Company Profiles
11.1 Company Evaluation Matrix Definitions and Methodology
11.1.1 Market Player Ranking, 2019
11.2 Company Evaluation Matrix
11.2.1 Stars
11.2.2 Emerging Leaders
11.2.3 Pervasive Players
11.2.4 Participants
11.3 Competitive Leadership Mapping (Start-Ups)
11.3.1 Progressive Companies
11.3.2 Starting Blocks
11.3.3 Responsive Companies
11.3.4 Dynamic Companies
11.4 Company Profiles
11.4.1 Labcorp
11.4.2 Quest Diagnostics
11.4.3 Alere
11.4.4 Orasure
11.4.5 Alfa Scientific Designs
11.4.6 Thermo Fisher Scientific
11.4.7 Dragerwerk
11.4.8 Lifeloc
11.4.9 Mpd Inc.
11.4.10 Omega Laboratories
11.4.11 Premier Biotech
11.4.12 Psychemedics
11.4.13 Roche
11.4.14 Shimadzu
11.4.15 Siemens Healthineers
11.4.16 American Bio Medica Corporation
11.4.17 Sciteck, Inc.
11.4.18 Acm Global Laboratories
11.4.19 Carehealth America
11.4.20 Clinical Reference Laboratory
12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: The Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details
For more information about this report visit https://www.researchandmarkets.com/r/law28m
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.